Sumatriptan may finally relieve French headachesBMJ 1994; 309 doi: https://doi.org/10.1136/bmj.309.6954.561 (Published 03 September 1994) Cite this as: BMJ 1994;309:561
- A Dorozynski
Four years after Glaxo made its first application to market sumatriptan in France the antimigraine drug is still not available in pharmacies - at least, not legally. But an agreement between Glaxo's French subsidiary and the French ministry of health and social affairs may enable doctors to prescribe the drug and some patients to be partly reimbursed for it through the social security system. The problem is money. Glaxo originally wanted to charge Fr170 (about £20) for an injectable dose and Fr90 (£10.50) …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial